NASDAQ:COCH Envoy Medical (COCH) Stock Price, News & Analysis $6.72 +0.02 (+0.22%) As of 03:35 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Envoy Medical Stock (NASDAQ:COCH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Envoy Medical alerts:Sign Up Key Stats Today's Range$6.50▼$6.8550-Day Range$5.96▼$7.4352-Week Range$3.63▼$9.54Volume21,526 shsAverage Volume38,842 shsMarket Capitalization$52.01 millionP/E RatioN/ADividend YieldN/APrice Target$21.00Consensus RatingHold Company Overview Envoy Medical is a medical technology company focused on developing implantable hearing devices. Based in White Bear Lake, Minnesota, the company was founded in 1995 and specializes in technologies intended to help people with hearing loss. Its product portfolio includes the Esteem Active Middle Ear Implant, an FDA-approved fully implanted hearing device for adults with moderate to severe sensorineural hearing loss. The company is also developing Acclaim, a fully implanted cochlear implant designed for people with severe to profound hearing loss. Acclaim remains investigational and is not approved for commercial use.AI Generated. May Contain Errors. Read More Envoy Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks62nd Percentile Overall ScoreCOCH MarketRank™: 3.082557502735 of 5 starsEnvoy Medical scored higher than 62% of companies evaluated by MarketBeat, and ranked 341st out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingHold Consensus RatingEnvoy Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialEnvoy Medical has a consensus price target of $21.00, representing about 207.7% upside from its current price of $6.82.Amount of Analyst CoverageEnvoy Medical has only been the subject of 3 research reports in the past 90 days.Read more about Envoy Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Envoy Medical are expected to grow in the coming year, from ($2.61) to ($2.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Envoy Medical is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Envoy Medical is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.26% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 2.67, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Envoy Medical has recently decreased by 84.42%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEnvoy Medical does not currently pay a dividend.Dividend GrowthEnvoy Medical does not have a long track record of dividend growth. News and Social Media2.2 / 5News SentimentN/A News SentimentEnvoy Medical has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.MarketBeat Follows2 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Envoy Medical insiders have not sold or bought any company stock.Percentage Held by Insiders7.20% of the stock of Envoy Medical is held by insiders.Percentage Held by Institutions8.59% of the stock of Envoy Medical is held by institutions.Read more about Envoy Medical's insider trading history. Receive COCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COCH Stock News HeadlinesFY2026 EPS Forecast for Envoy Medical Increased by AnalystNovember 13, 2026 | americanbankingnews.comEnvoy Medical, Inc. (NASDAQ:COCH) Shares Shorted: Short Interest Down 84.4% in OctoberNovember 11, 2026 | americanbankingnews.comAre Tesla and SpaceX Going Bankrupt?Tesla and SpaceX shares crashed right after Democrats took the House and the Senate in the midterm election. Elon Musk backed President Trump and donated millions to Republicans, and many believe he will become a political target. Brownstone Research founder Jeff Brown has seen Musk's new technology on camera. He says he is more convinced than ever that nothing can stop the coming Elon Musk revolution.November 20 at 1:00 AM | Brownstone Research (Ad)HC Wainwright Reaffirms Buy Rating for Envoy Medical (NASDAQ:COCH)November 11, 2026 | americanbankingnews.comEnvoy (COCH) Q3 2026 Earnings Call TranscriptNovember 5, 2026 | finance.yahoo.comEnvoy Medical Reports Third Quarter 2026 Results and Highlights Continued ProgressNovember 5, 2026 | marketscreener.comMEnvoy Medical Q3 2026 earnings call transcriptNovember 5, 2026 | msn.comEarnings To Watch: Envoy Medical Inc (COCH) Q3 2026 -- GF Value Sees 30% DownsideNovember 4, 2026 | finance.yahoo.comSee More Headlines COCH Stock Analysis - Frequently Asked Questions How have COCH shares performed this year? Envoy Medical's stock was trading at $6.6110 on January 1st, 2026. Since then, COCH shares have increased by 3.2% and is now trading at $6.8240. How were Envoy Medical's earnings last quarter? Envoy Medical, Inc. (NASDAQ:COCH) issued its earnings results on Thursday, November, 5th. The company reported ($0.50) earnings per share for the quarter, topping analysts' consensus estimates of ($0.67) by $0.17. The business earned $66 thousand during the quarter, compared to the consensus estimate of $85 thousand. When did Envoy Medical's stock split? Envoy Medical shares reverse split before market open on Monday, October 26th 2026.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, October 25th 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are Envoy Medical's major shareholders? Envoy Medical's top institutional shareholders include Nantahala Capital Management LLC (99.46%). Insiders that own company stock include Glen A Taylor, Charles Brynelsen, Mona Chetan Patel, Brent T Lucas, Robert Potashnick and Susan Kantor. View institutional ownership trends. How do I buy shares of Envoy Medical? Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Envoy Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Envoy Medical investors own include Grab (GRAB), Reviva Pharmaceuticals (RVPH), Sintx Technologies (SINT), Archer Aviation (ACHR), Allurion Technologies (ALUR), Virgin Galactic (SPCE) and AT&T (T). Company Calendar Last Earnings11/05/2026Today11/20/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 COCH's financial health is in the Yellow zone, according to TradeSmith. COCH has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:COCH CIK1840877 Webwww.envoymedical.com Phone(651) 361-8000FaxN/AEmployees47Year FoundedN/APrice Target and Rating Average Price Target for Envoy Medical$21.00 High Price Target$25.00 Low Price Target$18.00 Potential Upside/Downside+212.7%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($4.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$23.76 million Net Margins-9,026.41% Pretax Margin-9,026.41% Return on EquityN/A Return on Assets-112.19% Debt Debt-to-Equity RatioN/A Current Ratio1.21 Quick Ratio1.10 Sales & Book Value Annual Sales$231 thousand Price / Sales225.14 Cash FlowN/A Price / Cash FlowN/A Book Value($0.20) per share Price / Book-33.58Miscellaneous Outstanding Shares7,745,000Free Float7,187,000Market Cap$52.01 million OptionableNot Optionable Beta2.03 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:COCH) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersI tested Elon's new tech myself and brought a camera crewElon Musk's new technology is already in 229 locations across 27 states plus D.C. In 2016, Forbes called testi...Brownstone Research | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.